Stock Earnings

Question 1

What are Ginkgo Bioworks Holdings Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Ginkgo Bioworks Holdings Inc has a total asset of $1,119, Net loss of $-312

Question 2

What are the key financial ratios for DNA?

Accepted Answer

Ginkgo Bioworks Holdings Inc's Current ratio is 1.83, has a Net margin is -183.52, sales per share of $3.06.

Question 3

How is Ginkgo Bioworks Holdings Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Ginkgo Bioworks Holdings Inc data is not available.

Question 4

Is Ginkgo Bioworks Holdings Inc profitable?

Accepted Answer

no, according to the latest financial statements, Ginkgo Bioworks Holdings Inc has a net loss of $-312

Question 5

Does Ginkgo Bioworks Holdings Inc have any liabilities?

Accepted Answer

yes, Ginkgo Bioworks Holdings Inc has liability of 611

Question 6

How many outstanding shares for Ginkgo Bioworks Holdings Inc?

Accepted Answer

Ginkgo Bioworks Holdings Inc has a total outstanding shares of 58.2

Breakdown	TTM	12/31/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021
Revenue	111	170	227	251	477	313
Revenue Growth (YoY)	-52%	-25%	-10%	-47%	52%	312%
Cost of Revenue	24	46	44	54	204	129
Gross Profit	86	123	182	197	273	184
Selling, General & Admin	159	189	241	192	1,383	863
Research & Development	215	243	424	580	1,052	1,149
Operating Expenses	375	433	665	773	2,436	2,012
Other Non Operating Income (Expenses)	1	1	28	14	132	80
Pretax Income	-295	-313	-547	-892	-2,121	-1,838
Income Tax Expense	0	0	0	0	-15	-1
Net Income	-290	-312	-547	-892	-2,104	-1,830
Net Income Growth	-8%	-43%	-39%	-57.99%	15%	1,352%
Shares Outstanding (Diluted)	62.09	55.45	51.89	48.61	1,679.1	1,359.8
Shares Change (YoY)	13%	7%	7%	-97%	23%	-27%
EPS (Diluted)	-4.68	-5.63	-10.54	-18.36	-1.25	-1.35
EPS Growth	-18%	-47%	-43%	1,369%	-7%	1,829%
Free Cash Flow	-174	-178	-382	-336	-304	-310
Free Cash Flow Per Share	-2.8	-3.2	-7.36	-6.91	-0.18	-0.22
Gross Margin	77.47%	72.35%	80.17%	78.48%	57.23%	58.78%
Operating Margin	-259.45%	-181.76%	-212.77%	-229.48%	-453.24%	-584.02%
Profit Margin	-261.26%	-183.52%	-240.96%	-355.37%	-441.09%	-584.66%
Free Cash Flow Margin	-156.75%	-104.7%	-168.28%	-133.86%	-63.73%	-99.04%
EBITDA	-236	-251	-420	-506	-2,120	-1,799
EBITDA Margin	-212.61%	-147.64%	-185.02%	-201.59%	-444.44%	-574.76%
D&A For EBITDA	52	58	63	70	42	29
EBIT	-288	-309	-483	-576	-2,162	-1,828
EBIT Margin	-259.45%	-181.76%	-212.77%	-229.48%	-453.24%	-584.02%
Effective Tax Rate	0%	0%	0%	0%	0.7%	0.05%

Ginkgo Bioworks Holdings Inc (DNA) Price